PERSONALIZED GENE THERAPY TREATMENTS FOR CANCER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Personalized Gene Therapy Treatments For Cancer Market, By Therapy Type (Viral Vector-Based, Non-Viral Vector-Based, CRISPR-Cas9 Based, RNA-Based, and Others), By Cancer Type (Hematologic Cancer, Solid Tumors, Rare Cancers, and Others), By End-User (Hospitals & Specialty Clinics, ResearchInstitutes, and Contract Development & Manufacturing Organizations(CDMOs)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 07 Jan, 2026
Code: CMI60
Formats: Excel and PDF
Industry: Biotechnology
- Historical Range : 2020 - 2024
- Estimated Year : 2025
- Forecast Period : 2026 - 2033

N/A

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Preview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Therapy Type
  - Market Snapshot, By Cancer Type
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Partnership Scenario
- Brand and Pricing Analysis
- Distributors Landscape
- Porters Analysis
- Technological Advancements
- Key Developments
- Market Trend
- Future Prospective
- Top Market Players by Revenue
Personalized Gene Therapy Treatments For Cancer Market By Therapy Type, 2026–2033, (US$ Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- Viral Vector-Based
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Non-Viral Vector-Based
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- CRISPR-Cas9 Based
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- RNA-Based
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Personalized Gene Therapy Treatments For Cancer Market By Cancer Type, 2026-2033, (US$ Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- Hematologic Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Solid Tumors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Rare Cancers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Personalized Gene Therapy Treatments For Cancer Market By End User, 2026-2033, (US$ Billion)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022–2033
  - Segment Trends
- Hospitals & Specialty Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Research Institutes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Contract Development & Manufacturing Organizations (CDMOs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Personalized Gene Therapy Treatments For Cancer Market By Region, 2026-2033, (US$ Billion)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, For Regions, 2022–2033
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, en2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Benelux
    - Denmark
    - Norway
    - Sweden
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)
    - China
    - Taiwan
    - India
    - Japan
    - Indonesia
    - Malaysia
    - Philippines
    - Singapore
    - Australia
    - South Korea
    - Rest of Asia Pacific

o Middle East & Africa

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2026-2033, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2026-2033, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)
- Bahrain
- Kuwait
- Oman
- Qatar
- Saudi Arabia
- UAE
- Israel
- South Africa
- North Africa
- Central Africa
- Rest of the Middle East

Competitive Landscape
- Takeda Pharmaceutical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Celyad Oncology
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Audentes Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PTC Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Beam Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Moderna Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- MeiraGTx
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Regenxbio
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Homology Medicines
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- TCR2 Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now